The insulin-like growth factor 1 receptor in cancer: Old focus, new future

被引：144

作者：

Hartog, Hermien

Wesseling, Jelle

Boezen, H. Marike

van der Graaf, Winette T. A.

机构：

[1] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6500 HB Nijmegen, Netherlands

[2] Univ Groningen, Med Ctr, Dept Oncol, Groningen, Netherlands

[3] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands

[4] Univ Groningen, Med Ctr, Dept Epidemiol, Groningen, Netherlands

来源：

EUROPEAN JOURNAL OF CANCER | 2007年 / 43卷 / 13期

关键词：

insulin-like growth factor 1 receptor; insulin receptor; hybrid receptor; tyrosine kinase inhibitors; targeted therapy; growth factor receptor; antibody; cancer;

D O I：

10.1016/j.ejca.2007.05.021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The importance of insulin-like growth factor I receptor (IGF-1R) signalling in malignant behaviour of tumour cells is well established. Currently, development of drugs targeting the IGF-1R as anticancer treatment is emerging. Several IGF-1R targeting strategies are being investigated in phases 1 and 11 clinical trials. interactions of IGF-1R with insulin receptor, however, might complicate efficiency and tolerability of such drugs. This review describes mechanisms, recent developments and potential limitations of IGF-1R antibodies and tyrosine kinase inhibitors. (C) 2007 Elsevier Ltd. All rights reserved.

引用

收藏

页码：1895 / 1904

页数：10

相关论文

共 106 条

[71] IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer [J].

Peters, G ;

Gongoll, S ;

Langner, C ;

Mengel, M ;

Piso, P ;

Klempnauer, J ;

Rüschoff, J ;

Kreipe, H ;

von Wasielewski, R .

VIRCHOWS ARCHIV, 2003, 443 (02) :139-145

[72]

PEYRAT JP, 1988, CANCER RES, V48, P6429

[73] THE PROGNOSTIC VALUE OF INSULIN-LIKE GROWTH-FACTOR-I IN BREAST-CANCER PATIENTS - RESULTS OF A FOLLOW-UP-STUDY ON 126 PATIENTS [J].

RAILO, MJ ;

VONSMITTEN, K ;

PEKONEN, F .

EUROPEAN JOURNAL OF CANCER, 1994, 30A (03) :307-311

[74] Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis [J].

Renehan, AG ;

Zwahlen, M ;

Minder, C ;

O'Dwyer, ST ;

Shalet, SM ;

Egger, M .

LANCET, 2004, 363 (9418) :1346-1353

[75]

RESNICOFF M, 1994, CANCER RES, V54, P4848

[76] The insulin receptor is essential for virus-induced tumorigenesis of Kaposi's sarcoma [J].

Rose, P. P. ;

Carroll, J. M. ;

Carroll, P. A. ;

DeFilippis, V. R. ;

Lagunoff, M. ;

Moses, A. V. ;

Roberts, C. T., Jr. ;

Fruh, K. .

ONCOGENE, 2007, 26 (14) :1995-2005

[77] Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer [J].

Ryan, Charles J. ;

Haqq, Christopher M. ;

Simko, Jeffrey ;

Nonaka, Daisuke F. ;

Chan, June M. ;

Weinberg, Vivian ;

Small, Eric J. ;

Goldfine, Ira D. .

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2007, 25 (02) :134-140

[78] Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: Implications for anti-insulin-like growth factor therapy in breast cancer [J].

Sachdev, D ;

Singh, R ;

Fujita-Yamaguchi, Y ;

Yee, D .

CANCER RESEARCH, 2006, 66 (04) :2391-2402

[79] Disrupting insulin-like growth factor signaling as a potential cancer therapy [J].

Sachdev, Deepali ;

Yee, Douglas .

MOLECULAR CANCER THERAPEUTICS, 2007, 6 (01) :1-12

[80] The role of the IGF system in cancer growth and metastasis: Overview and recent insights [J].

Samani, Amir Abbas ;

Yakar, Shoshana ;

LeRoith, Derek ;

Brodt, Pnina .

ENDOCRINE REVIEWS, 2007, 28 (01) :20-47

← 2 3 4 5 6 7 8 9 10 11 →